To mark November’s National Diabetes Awareness Month, JDRF was thrilled to announce a new investment…
karnottNovember 7, 2024
Adverse drug reactions are a significant challenge in modern medicine, particularly in cancer treatment where…
karnottNovember 6, 2024
Congratulations to the DMCBH trainees who are among the 44 emerging researchers being funded by…
karnottNovember 5, 2024
Neonatal sepsis is a deadly disease with non-specific clinical signs, delaying diagnosis and treatment. There…
karnottNovember 5, 2024
The Faculty of Pharmaceutical Sciences is proud to present TRxending, a podcast dedicated to exploring…
karnottNovember 4, 2024
Dr. Cheryl Wellington’s lab recently acquired Canada’s first Alamar ARGO HT System, an advanced, fully…
karnottNovember 4, 2024
Michael Smith Health Research BC’s Scholar and Health Professional-Investigator (HP-I) awards provide funding to support…
karnottNovember 4, 2024
Dr. Carol Chen, one of the DMCBH’s newest faculty members, is on a mission to…
karnottNovember 1, 2024
Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional…
karnottNovember 1, 2024
